Acrodermatitis enteropathica (McKusick 20110) was probably described first by Wende (1902) and a further analysis of the disease by Brandt (1936) enabled Danbolt and Closs (1942) to recognize it as a distinct entity to which they gave its current name.
Acrodermatitis enteropathica is a rare condition inherited in an autosomal recessive manner. The parents are consanguineous in about 10 % of reported cases, the sexes are affected equally and on the basis of accurate case reports a sibship segregation ratio of 2.7:1 may be calculated.
Acrodermatitis enteropathica is characterized by a classic tetrad of mental depression, circumorificial and acral dermatitis, alopecia and diarrhoea. The untreated disease usually follows a progressive course with an unpredictable pattern of remissions and relapses which culminates during childhood with cachexia and a fatal infection. Brandt (1936) noted that the features of the disease did not appear in infants until breast feeding was supplemented by other foodstuffs. Furthermore, these signs were relatively minor until breast feeding was totally discontinued and clinical remissions could be induced with human breast milk. This provided the main treatment until Dillaha and colleagues (1953) reported the therapeutic efficacy of 5,7-diiodo-8-hydroxyquinoline (DIH), an 8-hydroxyquinoline derivative which had been used successfully earlier by Elias H. Schlomovitz. Many related chelating compounds have since been similarly efficacious (Neldner and Hambidge, 1975; Aggett et al., 1979) . Their use improved dramatically both the ability to diagnose Acrodermatitis enteropathica and its prognosis.
The pathogenesis of Acrodermatitis enteropathica remained obscure, however, until Moynahan and Barnes (1973) described a child with Acrodermatitis enteropathica who was on a lactose-free milk preparation and who had been unresponsive to DIH therapy until she was given zinc supplements to correc~ a calculated deficiency of zinc in her diet. Moynahan (1974) confirmed subsequently the effectiveness of oral zinc in Acrodermatitis enteropathica and described the similarity of the clinical features to those of zinc deficiency in animals and to the possibly homologous A46 trait in Friesian cattle (Chesters, 1983) . The importance of this serendipitous finding in understanding the pathophysiology of the disease and in managing the persistent skin rashes of some intravenously fed patients (Kay et aI., 1976) became appreciated rapidly.
PATHOGENESIS
The basic defect in Acrodermatitis enteropathica has not been identified but it is probably related to an impairment of the intestinal absorptive mechanism for zinc. The intestinal absorption of 65Zn by young patients with Acrodermatitis enteropathica is reduced (Lombeck et al., 1975; Weissmann et al., 1979) . Surprisingly in the light of clinical experience this defect was not shown in adult patients (Weissmann et al., 1979) . Since a considerable amount of zinc is secreted by the intestinal mucosa and pancreas it is also intriguing that there was no evidence of any increased loss of endogenous zinc in these patients. Metabolic balance studies of patients have shown net intestinal secretion of zinc in the untreated state which can be reversed by DIH or by large supplements of zinc orally (Aggett et al., 1978; Aggett et al., 1979) or by both (Jackson, 1977) to net absorption of the element. Hambidge and colleagues (1978) found a reduced concentration of zinc in a small intestinal biopsy from an untreated patient and postulated that, in Acrodermatitis enteropathica, intestinal uptake of zinc may be abnormal. Studies in vitro have shown impaired accumulation of 65Zn by proximal jejunal small intestinal biopsies from treated and untreated patients (Atherton et al., 1979) .
Evidence for a defect in the uptake of zinc by the enterocyte can be inferred from the observation that amphotericin induced a resolution in the symptoms of a child with Acrodermatitis enteropathica on an inadequate oral zinc supplement (Aggett et al., 1981 b) . This polyene antiobiotic, which is poorly absorbed, forms non-specific pores in biomembranes and it increases the permeability of lipid bilayers to a number of divalent cations including zinc (Aggett et aI., 1982) . Since amphotericin does not chelate metals it is possible that it achieved its therapeutic effect by forming pores in the enterocyte brush border membrane, thereby bypassing the postulated defect in zinc transport.
The analogy between Acrodermatitis enteropathica and primary hypomagnesaemia has been pointed out by Lombeck et al. (1975) . In the latter condition mucosal uptake in vivo of magnesium is defective at low intraluminal concentrations but normal at high concentrations; this infers the existence of two carrier mechanisms for magnesium (Milla et al., 1979) . Perhaps the same applies for the absorption of zinc by mammalian intestine (Davies, 1980) . Metal interactions such as those described earlier in this symposium (Aggett and Davies, 1983) suggest that normal zinc carrier mechanisms may not be specific. It is noteworthy, however, that our studies have shown net intestinal loss of iron and manganese in untreated patients with Acrodermatitis enteropathica (Aggett e~ al., 1981a) . This reverted after zinc supplementation and may reflect a wider impairment of intestinal function secondary to zinc deficiency. The high oral zinc doses did not affect copper status in our patients but this interaction has been reported in one infant (Hambidge et al., 1978) .
The reason for the therapeutic efficacy of breast milk compared to the deleterious effect of cows' milk has not been elucidated and has stimulated much interest in the role of exogenous zinc binding factors and in the distribution of zinc amongst the various ligands in milks. A discussion of these is beyond the scope of this review but current controversy (Cousins and Smith, 1980) reigns between the relative merits, if any, of picolinic acid (Krieger and Evans, 1980) and citric acid (Lonnerdal et al., 1980) . Addition~/lly the essential fatty acid content of milk may be relevant (Cunnane, 1982) . Picolinic acid, a derivative oftryptophan, has been reported to be of value in the management of Acrodermatitis enteropathica (Krieger and Evans, 1980) , but it does not improve the bioavailability of zinc in cattle with A46 trait (Flagstad, 1981) and neither it nor citrate enhances the bioavailability of zinc in healthy volunteers (Casey et al., 1980) . Nevertheless, altered zinc binding in duodenal juice has been described in Acrodermatitis enteropathica. This could represent the existence of an endogenous intraluminal binding thctor, loss of which is compensated by a similar factor in homologous breast milk (Casey et al., 1979) . Such a defect would be additional to the proven mucosal defect. The systemic metabolism of, and requirements for, zinc have not been investigated systematically in Acrodermatitis enteropathica, but the)" may be normal (Frier and Jungreis, 1976) . CLINICAL ASPECTS Affected children are apparently healthy at birth and have a normal birth weight. The clinical features (Table 1) are those of a profound zinc deficiency and their pathophysiology can be deduced from the preceding contributions in this symposium (Vallee, 1983; Chesters, 1983) . The classic onset (Brandt, 1936) usually means that clinical features develop during infancy, consequently one feels dubious about reports of cases with a later onset (Wells and Winkelmann, 1961) .
The 'dejected attitude of afflicted children' (Wells and Winkelmann, 1961) is as striking as is its rapid response within 1-3 days of starting zinc therapy. Subsequent deterioration in affect is the earliest evidence of inadequate treatment. Some adult patients in the 'prezinc era' had histories of neuropsychiatric illness (Olhotm-Larsen, 1979; Graves et at., 1980 ). An insight into the neurophysiological role of zinc is shown in the conduction defects of hippocampal mossy fibres in zinc deficient rats (Hesse, 1979) . Additional neurological features include ataxia (Aguilera-Diaz, 1971 ) and cerebral atrophy (Ohlsson, 1981) . It is reassuring that the subsequent IQ of patients appears to be unimpaired by previous zinc deficiency.
Aggett
The nail changes and dermatitis are usually symmetrical and their appearance may be preceded by swelling of the terminal phalanges and sometimes by 'prickling' sensations or distinct pain in the affected areas. In some cases the skin rash extends to the trunk and occasionally Staphylococcus aureus and Candida albicans can be isolated from the lesions. Alopecia may be total and hair loss may continue after therapy has been started. The hair in the untreated patient can be fine and brittle. The shaft exhibits trichonodosis with a varying calibre and a spearlike tip when viewed under polarized light (Dupre et al., 1979) . The range of eye lesions has been described by Matta and colleagues (1975) .
The role of zinc deficiency per se in causing hypogonadism is unclear. Hypogonadism has occurred in an 18-year-old youth with Acrodermatitis enteropathica (Gartside and Allen, 1975) , and an untreated female adult did not experience menarche until i9 years (Graves et al., 1980) . Growth retardation, however, is a distinct feature and untreated patients are in negative nitrogen balance (Aggett et al., 1981a) .
The immune defects in the disease relate to the role of zinc in cell mediated (Schloen et al., 1980) and humoral immunity (Beach et al., 1980) . Thymic hypoplasia (Rodin and Goldman, 1969; Julius et al., 1973) , impaired mitogenic response (Endre et aI., 1975) , and total absence of IgG and IgA (Julius et aI., 1973) have been described. More formal studies have shown zinc responsive impairments of monocyte and neutrophil chemotaxis (Weston et al., 1977) , cutaneous hypersensitivity reactions and in vitro lymphoblast responses (Chandra, 1980) . Diarrhoea was an important but not invariable feature of Acrodermatitis enteropathica (Wells and Winkelmann, 1961; Portnoy and Marsden, 1961) ; its development has become less frequent since clinical awareness has improved the early diagnosis of Acrodermatitis enteropathica. The aetiology of the watery diarrhoea is unknown; it may represent an intestinal infection or impaired mucosal function. Several intestinal mucosal lesions have been reported; these include a zinc responsive small intestinal villous atrophy (Kelly et al., 1976) , and inclusion bodies and abnormal intracellular organetles in the paneth cells and the enterocytes (Lombeck et al., 1974; Braun et al., 1976; Elm~ et aI., 1982; Neldner et at., 1974) . These changes are probably secondary to but not peculiar to zinc deficiency (Baudon et al., 1978; Elmes et al., 1982) . Mucosal disaccharidase activity may be reduced (Bohane et at., 1977) and some patients were intolerant of dietary lactose (Moynahan, 1973) . The latter have tolerated disaccharides normally since starting zinc therapy.
The clinical features may deteriorate during infection and the prepubertal growth spurt. They are less severe after puberty. In women, exacerbations can accompany menstruation and pregnancy.
Eleven reported pregnancies in patients with Acrodermatitis enteropathica untreated with zinc indicate the possible teratogenic effects of zinc deficiency in humans. One woman did not commence DIH treatment until the end of the first trimester and gave birth to an achondroplastic dwarf; her next three pregnancies whilst on DIH were normal (Epstein and Vedder, 1960) . Another woman had a spontaneous abortion and an anencephalic stillbirth (Neldner and Hambidge, 1975) and a third, a small woman, had a 2.52 kg infant (Verburg et al., 1974) . Both the latter women were receiving DIH. A fourth woman who had no treatment at all had two normal pregnancies followed by two pregnancies during which her disease deteriorated so much that therapeutic abortions were induced (01holm-Larsen, 1978). Recently two successful pregnancies during treatment with zinc sulphate have been described (Brenton et al., 1981) .
BIOCHEMICAL FEATURES
The biochemical abnormalities of Acrodermatitis enteropathica are inconsistent. A low plasma or serum zinc concentration can occur in conditions other than zinc deficiency (Aggett and Harries, 1979) and in Acrodermatitis enteropathica plasma zinc may remain depressed even though oral zinc supplements had improved skin lesions (Braun et al., 1976; OlholmLarsen, 1979) . Furthermore, zinc responsive features have been observed in treated patients with normal zinc concentrations (Robertson and Sotos, 1975) ; some patients have even presented with normal plasma or serum zinc concentrations (Garretts and Molokhia, 1977; Rogers, 1980; Krieger and Evans, 1980) . The latter patients need not represent a disease variant; their plasma zinc concentrations may reflect maintenance of the relatively small plasma zinc pool by release of the element during turnover of peripheral tissues. This possibility is illustrated by an untreated case whose plasma zinc concentration returned to normal following a laparotomy (Olholm-Larsen, 1978) .
Changes in the serum fatty acid profile reflect the role of zinc in the elongation and desaturation of essential fatty acids. Classically levels of 18:1 and 20:4 fatty acids are reduced and those of 18: 2 and trienes are increased (Cash and Berger, 1969) . These abnormalities have not been noted in adequately treated patients (Kayden and Cox, 1973) and are variable even in untreated cases (Julius et al., 1973; Braun et at., 1976; Aggett et al., 198ia) . Other laboratory observations include hypobetalipoproteinaemia (Neldner et al., 1974) , low serum vitamin A concentrations (Hambidge et al., 1978) and an elevated blood ammonia (Aggett et al., 1981a) .
DIAGNOSIS
The diagnosis of Acrodermatitis enteropathica remains essentially a clinical diagnosis in which monitoring plasma zinc concentrations and biochemical changes such as an increase in the activity of alkaline phosphatase (Weismann and Hoyer, 1979) are adjuncts to observing the clinical response following zinc supplementation. The differential diagnosis includes epidermolysis bullosa, moniliasis, psoriasis, familial benign chronic pemphigus, congenital ichthyosiform dermatitis and, in adults, necrolytic migratory erythema. To these must be added zinc deficiency secondary to protracted diarrhoeas and other similar paediatric disease states at risk of developing zinc deficiency (Aggett and Harries, 1979) . More recently a transient zinc deficiency syndrome has been described in breast-fed (Aggett et al., 1980) and cow milk formulae fed preterm (Bonifazi et al., 1980) and term infants. The presentation of these children was in every way identical to Acrodermatitis enteropathica except, of course, that some were being breast-fed. The breast-fed cases could represent an analogue of the lethal milk syndrome in mice (Chesters, 1983) but this is probably not so because a subsequent breast-fed preterm sibling of our case did not develop zinc deficiency and the syndrome has been seen also in only one of breast-fed dizygotic twins (Atherton, D. J., personal communication). None of these children needed prolonged zinc supplementation and this illustrates the point that Acrodermatitis enteropathica cannot be diagnosed reliably on the basis of the response to zinc supplements alone but that the effects of withdrawing such supplements need to be observed also.
As yet there is no way of detecting heterozygotes. Plasma zinc concentrations are unreliable (OlholmLarsen, 1979) . The absorption of zinc from orally administered pharmacological doses by heterozygotes is normal (Casey et at., 1980) , as is the intestinal absorption and whole body retention of65Zn (Lombeck et al., 1975) .
TREATMENT
Between 35 mg and 100 mg of elemental zinc in divided doses daily is usually adequate. Zinc sulphate heptahydrate (50 mg of elemental zinc in 220 rag) is used commonly but the aspartate, oxide and gluconate salts are available also. Individual requirements for zinc vary but are relatively greater during the anabolic responses following initiation of therapy, during early childhood and preceding puberty. Clinical experience suggests that the requirements for zinc are reduced following puberty; nevertheless, they persist. Brenton et al. (1981) found 200 mg and 300 mg of zinc sulphate daily adequate for the management of their young woman during her pregnancies.
The metallic taste of zinc solutions may make them unpalatable; furthermore, large doses can be nauseating. Fortunately, encapsulated forms of the zinc salts are available. Taking the zinc salt with food may improve its palatability but the amount of zinc absorbed may be reduced.
CONCLUSION
The discovery that Acrodermatitis enteropathica is a disorder involving the metabolism of zinc in man has provided a great impetus into research in this topic over the past decade. Much remains to be done and undoubtedly Acrodermatitis enteropathica will continue to provide insights into the physiological and biochemical role of zinc.
